KLKang Li

Kang Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Subjects


Kang Li has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Aobo Dong

    Chinese Center for Disease Control and Prevention, 12415, Division of Research on Virology and immunology, Beijing, China

    1 shared publication
  • Chang Song

    State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China, B, China;

    1 shared publication
  • Hui Xing

    National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention State Key Laboratory of Infectious Disease Prevention and Control (SKLID) Beijing 102206

    1 shared publication
  • Jihong Xing

    Xichang Center for Disease Control and Prevention, Xichang, China;

    1 shared publication
  • Jing Hu

    State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China

    1 shared publication
  • Jun Yin

    Xichang Center for Disease Control and Prevention, Xichang, China;

    1 shared publication

Latest Publications

  • First Detection of a Circulating Recombinant Form of HIV-1 CRF01_AE/08_BC (CRF105_0108) with Drug-Resistant Mutations in Sichuan, China

    by Aobo Dong, Lei Liu, Lin Xiao, Shu Liang, Kang Li, Jing Hu, Ruihua Kang, Jihong Xing, Chang Song, Jun Yin, et al.

    In this study, we identified a novel circulating recombinant form (CRF) of HIV (CRF105_0108) in a total of five patients with no obvious epidemiological linkage in Sichuan, China. Four strains were found in this study, and another strain (XC2014EU01) was reported in a previous study. The phylogenetic analysis of the five near full-length genomes showed that a CRF08_BC segment was inserted into the CRF01_AE backbone with one recombinant breakpoint in the pol region, which is the first HIV-1 CRF of CRF01_AE and CRF08_BC. Three genetic sequences had drug-resistant mutations, E138Q and V179D, indicating that there were low resistance levels to efavirenz (EFV) and nevirapine (NVP) in Liangshan Yi Autonomous Prefecture. CRF105_0108 increases the diversity and complexity of the prevalent HIV-1 CRFs in Sichuan. Simultaneously, drug-resistant mutations in this CRF may influence the efficacy of highly active antiretroviral treatments (ARTs) in Liangshan Yi Autonomous Prefecture.